Gerber Kawasaki Wealth & Investment Management Has $304,000 Stake in Danaher Co. (NYSE:DHR)

Posted by Defense World Staff on Sep 11th, 2023

Gerber Kawasaki Wealth & Investment Management decreased its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 26.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,206 shares of the conglomerate’s stock after selling 423 shares during the quarter. Gerber Kawasaki Wealth & Investment Management’s holdings in Danaher were worth $304,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Moneta Group Investment Advisors LLC increased its stake in shares of Danaher by 96,490.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after buying an additional 23,262,904 shares during the period. Geode Capital Management LLC increased its stake in shares of Danaher by 14.3% in the fourth quarter. Geode Capital Management LLC now owns 12,774,623 shares of the conglomerate’s stock valued at $3,384,177,000 after buying an additional 1,595,344 shares during the period. Norges Bank acquired a new position in shares of Danaher in the fourth quarter valued at approximately $2,057,164,000. Bank of New York Mellon Corp increased its stake in shares of Danaher by 12.3% in the first quarter. Bank of New York Mellon Corp now owns 7,440,410 shares of the conglomerate’s stock valued at $1,875,281,000 after buying an additional 812,475 shares during the period. Finally, Amundi increased its stake in shares of Danaher by 8.4% in the fourth quarter. Amundi now owns 4,852,751 shares of the conglomerate’s stock valued at $1,321,312,000 after buying an additional 375,805 shares during the period. Institutional investors and hedge funds own 76.71% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 3,490 shares of the firm’s stock in a transaction on Wednesday, July 26th. The stock was sold at an average price of $263.30, for a total transaction of $918,917.00. Following the transaction, the director now directly owns 17,494 shares in the company, valued at approximately $4,606,170.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Linda Filler sold 10,190 shares of the firm’s stock in a transaction on Friday, July 28th. The stock was sold at an average price of $260.25, for a total transaction of $2,651,947.50. Following the completion of the sale, the director now directly owns 38,152 shares of the company’s stock, valued at approximately $9,929,058. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Teri List sold 3,490 shares of the firm’s stock in a transaction on Wednesday, July 26th. The shares were sold at an average price of $263.30, for a total value of $918,917.00. Following the sale, the director now directly owns 17,494 shares of the company’s stock, valued at $4,606,170.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 47,922 shares of company stock worth $12,552,233. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of a number of recent analyst reports. Stifel Nicolaus decreased their target price on shares of Danaher from $250.00 to $240.00 and set a “hold” rating for the company in a research report on Wednesday, July 26th. Barclays increased their target price on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research report on Tuesday, July 25th. StockNews.com started coverage on shares of Danaher in a research report on Monday, September 4th. They set a “hold” rating for the company. Royal Bank of Canada increased their price target on Danaher from $260.00 to $292.00 in a report on Wednesday, July 26th. Finally, Bank of America increased their price target on Danaher from $250.00 to $280.00 in a report on Wednesday, July 26th. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $289.79.

Check Out Our Latest Analysis on DHR

Danaher Price Performance

Shares of DHR opened at $248.36 on Monday. Danaher Co. has a 12-month low of $221.22 and a 12-month high of $294.60. The business’s fifty day moving average is $251.78 and its 200 day moving average is $244.97. The company has a quick ratio of 1.70, a current ratio of 2.08 and a debt-to-equity ratio of 0.35. The stock has a market cap of $183.38 billion, a P/E ratio of 29.15, a P/E/G ratio of 2.75 and a beta of 0.80.

Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Tuesday, July 25th. The conglomerate reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.01 by $0.04. Danaher had a return on equity of 15.03% and a net margin of 20.95%. The company had revenue of $7.16 billion for the quarter, compared to analysts’ expectations of $7.12 billion. During the same period last year, the business earned $2.76 EPS. Danaher’s quarterly revenue was down 7.7% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Co. will post 8.84 earnings per share for the current fiscal year.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.